US health research estimates occupational injury and illness costs $250bn

5 April 2012 / United States

A US health researcher has published an assessment of the national economic burden of occupational injury and illness, concluding that the direct and indirect costs are greater than generally assumed and amount to a value of at least $250bn/yr, exceeding the individual cost of diseases such as cancer, coronary heart disease, stroke, and diabetes.

The author estimated the incidence of injuries, illnesses and diseases and the medical and productivity-related costs of such conditions, by combining several sources of information. This included data from the US Bureau of Labor Statistics (BLS), the Centers for Disease Control and Prevention (CDC) and costs data from the National Council on Compensation Insurance and the Healthcare Cost and Utilization Project. Secondary data from the National Academy of Social Insurance, literature estimates of Attributable Fractions (AF) of diseases with occupational components, and national estimates for all health care costs was also included.

This information was used to calculate that the medical cost estimates were $67bn, and indirect costs were almost $183bn.

The research is published in The Milbank Quarterly.

 
 

Further Information

Abstract

NIOSH review of study

 

Comment on this article in the Forum »

Previous article / Next article
Back to News / Back to Top

 

© CW Research Ltd. You may circulate web links to our articles, but you may not copy our articles in whole or in part without permission

CORRECTIONS: We strive for accuracy, but with deadline pressure, mistakes can happen. If you spot something, we want to know, please email us at: reportanerror@chemicalwatch.com
We also welcome YOUR NEWS: Send announcements to news@chemicalwatch.com

 

14 day free trial

Get unlimited access to Chemical Watch news and one monthly briefing.

Register